Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

Healthcare Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

Immunoprecise Antibodies Ltd > IPA has a Winner with AI
View:
Post by GoldenArm on Dec 01, 2022 9:46am

IPA has a Winner with AI

IPA's Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies

https://www.marketscreener.com/quote/stock/IMMUNOPRECISE-ANTIBODIES-40328863/news/IPA-s-Subsidiary-BioStrand-and-BriaCell-Announce-Artificial-Intelligence-Collaboration-and-License-A-42454282/

With BioStrand, IPA could have it hand in pockets of several emerging drugs which could (speculating here) make them a powerhouse drug company.
Comment by wallpaper2 on Dec 01, 2022 12:52pm
IPA has the potential to receive Royalties and upfront cash on dozens more drug discoveries. Personalized medicine is the wave of the future and lensAI can make it happen in a fraction of the time and cost. 2023 is shaping up to be a eye opener !! Sit tight and enjoy the ride.
Immunoprecise Antibodies Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities